CASE STUDY: HELIX AND HEALTHY NEVADA
Powering the world's fastest growing population health program in Nevada
Researchers at the Healthy Nevada Project had originally started with microarray data, but soon realized that they needed CLIA/CAP exome data to meet their goals. Our high-throughput sequencing lab made clinical-grade genomic data available that met their rigorous needs. We made recruitment easy, too: By offering participants a Helix account with informative, easy-to-use ancestry and traits apps, Helix and the Healthy Nevada Project stimulated demand, recruiting 10,000 Nevadans in less than a week. In less than one year, Healthy Nevada has assembled one of the largest genomic and health data sets in the world.
Looking for your results?
If you're a participant and have questions about your results or the study you participated in, we're happy to help!
Designed from the ground up to meet your needs
Helix's clinical-grade genomics platform offers you flexibility, delivering accurate and actionable results even as new discoveries are made.
Helix has dedicated bioinformatics, laboratory, and quality teams that are focused on ensuring the high-quality of data necessary to inform the broadest range of genetic insights.
CLIA/CAP Exome+ data
Exome+ is a proprietary assay that includes a medical exome as well as a microarray backbone to power research, clinical products, and nonclinical applications.3,4
Sequence once, query often
Only Helix sequences and securely stores a whole exome today on behalf of each participant. Access just the data you need; with the participant’s consent, you can come back for more when you’re ready.
An end-to-end approach to population genomics
Contact us to learn how Helix can enable your population health initiative
Driving a higher standard of care
Helix partners with health systems and research institutions to maximize the impact of the genome to prevent disease in your communities.
Identify at-risk members
Population health initiatives help you save lives today. In a health system serving one million people, 30,000 to 40,000 are carrying an ACMG 59 variant—and many aren’t aware. 67% of BRCA2 variant carriers have no family history of associated disease.2
Support your community
With genomic data in hand, your physicians, genetic counselors, and nurses can reach out to individuals to deliver positive findings and design clinical action plans.
A lifetime of benefit
Genomics on your terms
No matter your specialty or area of research, our flexibility enables you to add genomics to all of your initiatives at a pace that's right for you.
Provide ongoing updates
With Helix, your participants have all 20,000 genes on file, allowing you access to additional genetic insights over time with their consent.